Verrica Pharmaceuticals Inc. - 10-Q Filing

Verrica Pharmaceuticals reports Q3 2026 financial results including new secured debt obligations and derivative valuations.

SEC EDGAR ·

Tickers: $VRCA

Read the full article at SEC EDGAR

More Regulatory news